Humana Inc. (NYSE:HUM) Stock Holdings Increased by Quantinno Capital Management LP

Quantinno Capital Management LP lifted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 29.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,355 shares of the insurance provider's stock after acquiring an additional 2,151 shares during the quarter. Quantinno Capital Management LP's holdings in Humana were worth $2,374,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. FPC Investment Advisory Inc. acquired a new position in shares of Humana during the 4th quarter worth $27,000. Centricity Wealth Management LLC purchased a new stake in Humana during the fourth quarter worth about $30,000. LFA Lugano Financial Advisors SA boosted its holdings in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in Humana during the fourth quarter worth about $33,000. Finally, Transce3nd LLC purchased a new position in Humana in the fourth quarter valued at about $38,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

HUM traded down $2.33 during trading on Monday, reaching $224.81. 1,673,666 shares of the company were exchanged, compared to its average volume of 1,780,631. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a 50 day moving average of $261.17 and a 200 day moving average of $268.50. The stock has a market cap of $27.13 billion, a P/E ratio of 22.59, a PEG ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The company's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $7.23 EPS. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.57%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.

Wall Street Analyst Weigh In

A number of research firms have commented on HUM. Guggenheim started coverage on Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price on the stock. Raymond James upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a research report on Thursday, May 1st. Truist Financial cut their price target on shares of Humana from $325.00 to $305.00 and set a "hold" rating on the stock in a research note on Monday, May 12th. JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $286.81.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.